Side-by-side financials for ACET and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ACET | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #48 |
| Net income (latest FY) | -$116.80M | - |
| SEC filings | 658 | 1,004 |
Full pages: Adicet Bio, Inc. and AstraZeneca PLC, or browse the full rankings.